The Korsakoff syndrome: clinical aspects, psychology and treatment.
OBJECTIVE
The Korsakoff syndrome is a preventable memory disorder that usually emerges (although not always) in the aftermath of an episode of Wernicke's encephalopathy. The present paper reviews the clinical and scientific literature on this disorder.


METHODS
A systematic review of the clinical and scientific literature on Wernicke's encephalopathy and the alcoholic Korsakoff syndrome.


RESULTS
The Korsakoff syndrome is most commonly associated with chronic alcohol misuse, and some heavy drinkers may have a genetic predisposition to developing the syndrome. The characteristic neuropathology includes neuronal loss, micro-haemorrhages and gliosis in the paraventricular and peri-aqueductal grey matter. Lesions in the mammillary bodies, the mammillo-thalamic tract and the anterior thalamus may be more important to memory dysfunction than lesions in the medial dorsal nucleus of the thalamus. Episodic memory is severely affected in the Korsakoff syndrome, and the learning of new semantic memories is variably affected. 'Implicit' aspects of memory are preserved. These patients are often first encountered in general hospital settings where they can occupy acute medical beds for lengthy periods. Abstinence is the cornerstone of any rehabilitation programme. Korsakoff patients are capable of new learning, particularly if they live in a calm and well-structured environment and if new information is cued. There are few long-term follow-up studies, but these patients are reported to have a normal life expectancy if they remain abstinent from alcohol.


CONCLUSIONS
Although we now have substantial knowledge about the nature of this disorder, scientific questions (e.g. regarding the underlying genetics) remain. More particularly, there is a dearth of appropriate long-term care facilities for these patients, given that empirical research has shown that good practice has beneficial effects.
Kopelman
Michael D
MD
King's College London, Institute of Psychiatry, London, UK. michael.kopelman@kcl.ac.uk
Thomson
Allan D
AD
Guerrini
Irene
I
Marshall
E Jane
EJ
D000437:Alcoholism / Q000150:complications / Q000628:therapy; D001921:Brain / Q000473:pathology; D001923:Brain Chemistry / Q000235:genetics / Q000502:physiology; D006801:Humans; D020915:Korsakoff Syndrome / Q000139:chemically induced / Q000235:genetics / Q000523:psychology* / Q000628:therapy*; D014899:Wernicke Encephalopathy / Q000139:chemically induced / Q000235:genetics / Q000523:psychology / Q000628:therapy